197 related articles for article (PubMed ID: 18021496)
1. Switching from other antipsychotics to once-daily extended release quetiapine fumarate in patients with schizophrenia.
Ganesan S; Agambaram V; Randeree F; Eggens I; Huizar K; Meulien D;
Curr Med Res Opin; 2008 Jan; 24(1):21-32. PubMed ID: 18021496
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: a randomized, double-blind, placebo-controlled study.
Kahn RS; Schulz SC; Palazov VD; Reyes EB; Brecher M; Svensson O; Andersson HM; Meulien D;
J Clin Psychiatry; 2007 Jun; 68(6):832-42. PubMed ID: 17592906
[TBL] [Abstract][Full Text] [Related]
3. The long-term clinical benefit and effectiveness of switching to once-daily quetiapine extended release in patients with schizophrenia.
Chue P; Malla A; Bouchard RH; Lessard S; Ganesan S; Stip E; Johnson S; Chen E; Ahn YM; Kim YS; Robinson G; Schweikert C; Gendron A; Eriksson H;
Curr Med Res Opin; 2013 Mar; 29(3):227-39. PubMed ID: 23281876
[TBL] [Abstract][Full Text] [Related]
4. The efficacy and safety of once-daily quetiapine extended release in patients with schizophrenia switched from other antipsychotics: an open-label study in Chinese population.
Pan PY; Lee MS; Yeh CB
BMC Psychiatry; 2015 Jan; 15():1. PubMed ID: 25609320
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and tolerability of once-daily extended release quetiapine fumarate in hospitalized patients with acute schizophrenia: a 6-week randomized, double-blind, placebo-controlled study.
Lindenmayer JP; Brown D; Liu S; Brecher M; Meulien D
Psychopharmacol Bull; 2008; 41(3):11-35. PubMed ID: 18779774
[TBL] [Abstract][Full Text] [Related]
6. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
[TBL] [Abstract][Full Text] [Related]
7. A failed 6-week,randomized, double-blind, placebo-controlled study of once-daily extended release quetiapine fumarate in patients with acute schizophrenia: lessons learned.
Cutler AJ; Tran-Johnson T; Kalali A; Aström M; Brecher M; Meulien D
Psychopharmacol Bull; 2010; 43(4):37-69. PubMed ID: 21240151
[TBL] [Abstract][Full Text] [Related]
8. Switching from quetiapine to ziprasidone: a sixteen-week, open-label, multicenter study evaluating the effectiveness and safety of ziprasidone in outpatient subjects with schizophrenia or schizoaffective disorder.
Karayal ON; Glue P; Bachinsky M; Stewart M; Chappell P; Kolluri S; Cavus I
J Psychiatr Pract; 2011 Mar; 17(2):100-9. PubMed ID: 21430488
[TBL] [Abstract][Full Text] [Related]
9. Randomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder.
Katila H; Mezhebovsky I; Mulroy A; Berggren L; Eriksson H; Earley W; Datto C
Am J Geriatr Psychiatry; 2013 Aug; 21(8):769-84. PubMed ID: 23567397
[TBL] [Abstract][Full Text] [Related]
10. Quetiapine extended release: in schizophrenia.
Baldwin CM; Scott LJ
CNS Drugs; 2009; 23(3):261-9. PubMed ID: 19320534
[TBL] [Abstract][Full Text] [Related]
11. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG
Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196
[TBL] [Abstract][Full Text] [Related]
12. Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in patients with generalized anxiety disorder and a history of inadequate treatment response: a randomized, double-blind study.
Khan A; Atkinson S; Mezhebovsky I; She F; Leathers T; Pathak S
Ann Clin Psychiatry; 2013 Nov; 25(4):E7-22. PubMed ID: 24199224
[TBL] [Abstract][Full Text] [Related]
13. Safety of quetiapine fumarate extended release in the treatment of Korean patients with acute schizophrenia.
Lee JG; Lee JI; Kim YT; Kim CE; Kim CY; Yoon JS; Yoo SY; Kim YH
Hum Psychopharmacol; 2012 Jul; 27(4):403-10. PubMed ID: 22753400
[TBL] [Abstract][Full Text] [Related]
14. Rapid versus conventional initiation of quetiapine in the treatment of schizophrenia: a randomized, parallel-group trial.
Pae CU; Kim JJ; Lee CU; Lee SJ; Lee C; Patkar AA; Masand PS; Paik IH
J Clin Psychiatry; 2007 Mar; 68(3):399-405. PubMed ID: 17388709
[TBL] [Abstract][Full Text] [Related]
15. Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study.
El-Khalili N; Joyce M; Atkinson S; Buynak RJ; Datto C; Lindgren P; Eriksson H
Int J Neuropsychopharmacol; 2010 Aug; 13(7):917-32. PubMed ID: 20175941
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the quetiapine experience with safety and tolerability (QUEST) study.
Mullen J; Jibson MD; Sweitzer D
Clin Ther; 2001 Nov; 23(11):1839-54. PubMed ID: 11768836
[TBL] [Abstract][Full Text] [Related]
17. Quality of life and drug costs associated with switching antipsychotic medication to once-daily extended release quetiapine fumarate in patients with schizophrenia.
Järbrink K; Kreif N; Benedict A; Locklear J
Curr Med Res Opin; 2009 Mar; 25(3):709-16. PubMed ID: 19196221
[TBL] [Abstract][Full Text] [Related]
18. Double-blind, randomized study of extended release quetiapine fumarate (quetiapine XR) monotherapy in older patients with generalized anxiety disorder.
Mezhebovsky I; Mägi K; She F; Datto C; Eriksson H
Int J Geriatr Psychiatry; 2013 Jun; 28(6):615-25. PubMed ID: 23070803
[TBL] [Abstract][Full Text] [Related]
19. Treatment of depressive symptoms in patients with schizophrenia: a randomized, open-label, parallel-group, flexible-dose subgroup analysis of patients treated with extended-release quetiapine fumarate or risperidone.
Kasper S; Montagnani G; Trespi G; Di Fiorino M
Int Clin Psychopharmacol; 2015 Jan; 30(1):14-22. PubMed ID: 25356632
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the feasibility of switching from immediate release quetiapine to extended release quetiapine fumarate in stable outpatients with schizophrenia.
Möller HJ; Johnson S; Mateva T; Brecher M; Svensson O; Miller F; Meulien D;
Int Clin Psychopharmacol; 2008 Mar; 23(2):95-105. PubMed ID: 18301124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
